SENATE 1038118th CongressRead twice and referred to the Committee on Finance.
Drug Price Transparency in Medicaid Act of 2023
- Last Action
- 3/29/2023
Actions
- 2023-03-29Read twice and referred to the Committee on Finance.
- 2023-03-29Introduced in Senate
CRS Summary
As of 2023-03-29 (00)
Drug Price Transparency in Medicaid Act of 2023
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
Cosponsors (3)
- Roger Marshall (R-KS)
- Shelley Capito (R-WV)
- Kirsten Gillibrand (D-NY)
Subjects
- Business records
- Congressional oversight
- Government information and archives
- Health care costs and insurance
- Home and outpatient care
- Inflation and prices
- Medicaid
- Prescription drugs
- Public contracts and procurement
- Retail and wholesale trades
- State and local government operations
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.